Metropolis Healthcare has received approval for the acquisition of balance Equity stake of 35% i.e. 10,50,000 Equity shares of Rs 10 each in Metropolis Histoxpert Digital Services (Histoxpert). The object of acquisition is to ensure complete control over the affairs of Histoxpert and ensure operational efficiency. The Board of Directors of the company at their meeting held on August 11, 2020 has approved the same.
Metropolis Healthcare offers a comprehensive range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.
